Skip to Content

niraparib 100 mg (Zejula 100 mg)

Generic Name: niraparib

Pill with imprint niraparib 100 mg is Purple / White, Capsule-shape and has been identified as Zejula 100 mg. It is supplied by Tesaro Inc..

Zejula is used in the treatment of ovarian cancer; fallopian tube cancer; peritoneal cancer and belongs to the drug class PARP inhibitors. Zejula 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for niraparib 100 mg

Zejula

Generic Name:
niraparib
Imprint:
niraparib 100 mg
Strength:
100 mg
Color:
Purple / White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
PARP inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Tesaro Inc.
National Drug Code (NDC):
69656-0103

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide